Correction to: Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)
2015 ◽
Vol 170
(4)
◽
pp. 675-682.e8
◽
2017 ◽
Vol 120
(10)
◽
pp. 1837-1840
◽
Keyword(s):
2010 ◽
Vol 159
(3)
◽
pp. 340-347.e1
◽
Keyword(s):
Keyword(s):
2017 ◽
Vol 119
(12)
◽
pp. 1989-1996
◽
Keyword(s):
2014 ◽
Vol 167
(5)
◽
pp. 646-652
◽